Skip to content

Life Sciences

Our global Life Sciences practice comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, veterinary, medtech, diagnostics and healthcare sectors.

The practice operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (both contentious and non-contentious), capital markets and finance, regulatory and dispute resolution. Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are well positioned to advise on cross-border work.

We have won a reputation for providing far-sighted advice to some of the world’s leading life science companies – including GlaxoSmithKline, Pfizer, UCB, Merck, Bayer and Novartis.

News & insights

News: 30 JULY 2021

Allen & Overy conseille Wren House sur sa prise de participation majoritaire dans Almaviva Santé

Allen & Overy a conseillé Wren House, fonds mondial d'investissements spécialisé dans le financement d’infrastructures, dans le cadre de son entrée en négociations exclusives avec Antin Infrastructure…

Lire la suite

News: 28 JULY 2021

Allen & Overy sur le financement PIK dans le cadre de l’acquisition du groupe Lagarrigue par Naxicap Partners

Allen & Overy Paris a conseillé CIC Private Debt sur le financement PIK dans le cadre de l’acquisition par Naxicap Partners auprès d’Ardian Expansion d’une participation majoritaire dans le groupe…

Lire la suite

News: 23 JULY 2021

Une croissance exceptionnelle de la valeur des opérations de fusions-acquisitions au premier semestre 2021

La période particulière qu’a constitué la première moitié de 2020 explique en partie la forte augmentation de 131 % en valeur des transactions M&A dans le monde, observée en comparaison depuis le…

Lire la suite
A&O sign

News: 28 JUNE 2021

Deux associées d’Allen & Overy distinguées lors des Women In Business Law Awards Europe 2021

Laëtitia Bénard (Paris) et Denise Gibson (Londres), associées et membres du conseil d’administration du cabinet international d’avocats d’affaires Allen & Overy, ont toutes deux été récompensées lors…

Lire la suite

Distinction

Related links

Life Sciences Hub

We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector.

Read more

CRISPR microsite

The characterisation and optimisation of the CRISPR (also known as CRISPR-Cas) system for gene editing and other applications, is undoubtedly one of the most powerful and ground breaking advances in the history of biotechnology.

Go to microsite

Growth Capital microsite

Allen & Overy is an engaged and active player in the growth company ecosystem.

Go to microsite

Cannabis microsite

According to UN estimates, the global cannabis market is currently worth approximately USD150 billion annually. 

Go to microsite

Download our sector brochure

An insight in to our Life Science and Healthcare sector 2021

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.

Related content

Global trends in merger control enforcement

Record levels in the first half of 2018 and considerable contraction in the second.